You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Complementary medicines filter Complementary medicines (7)
- Remove Fees/Payments filter Fees/Payments (1)
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (7) Apply Prescription medicines filter
- Scheduling (56) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Remove Therapeutic goods regulation filter Therapeutic goods regulation (3)
- (-) Remove Medicinal cannabis filter Medicinal cannabis
- (-) Remove Therapeutic goods regulation filter Therapeutic goods regulation
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Complementary medicines filter Complementary medicines
- (-) Remove Fees/Payments filter Fees/Payments
Adoption of International Scientific Guidelines in Australia
Closed on 29 July 2022
Proposed update to the evidence guidelines for listed medicines
Closed on 1 April 2022
Fees and Charges Proposal 2022-23
Closed on 7 March 2022
Discussion paper on potential for mandatory reporting of medical device adverse events by healthcare facilities in Australia
Closed on 13 December 2021
Consultation on Draft Guidance: Assistive Technologies and the Therapeutic Goods (Excluded Goods) Determination 2021
Closed on 22 October 2021
Proposed refinements to the regulation of medical devices that are substances introduced into the human body via a body orifice or applied to the skin
Closed on 13 August 2021
Proposed refinements to the regulation of personalised medical devices
Closed on 14 July 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Sedating antihistamines
Closed on 18 May 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Menthol
Closed on 18 May 2021